D.C. Code § 38-651.02
(a) A student may possess and self-administer medication or non-medication seizure treatment at the school in which the student is currently enrolled, at school-sponsored activities, and while on school-sponsored transportation, in order to treat asthma, anaphylaxis, a seizure disorder, or other illness; provided, that:
(b)
Feb. 2, 2008, D.C. Law 17-107, § 3, 54 DCR 12230
Apr. 16, 2020, D.C. Law 23-81, § 3(b)
Mar. 7, 2025, D.C. Law 25-272, § 2(b)
For temporary (90 day) addition, see § 3 of Student Access to Treatment Congressional Review Emergency Act of 2007 (D.C. Act 17-140, October 17, 2007, 54 DCR 10736).
For temporary (90 day) addition, see § 3 of Student Access to Treatment Emergency Amendment Act of 2007 (D.C. Act 17-82, July 26, 2007, 54 DCR 7999).
For temporary (90 days) amendment of this section, see § 2(b) of School Sunscreen Safety Emergency Amendment Act of 2019 (D.C. Act 23-124, Oct. 7, 2019, 66 DCR 13156).
Section 11(b) of D.C. Law 17-52 provided that the act shall expire after 225 days of its having taken effect.
“(2) All other conditions set forth in this act, or in rules promulgated pursuant to this act, are met.”
“(1) The responsible person has submitted a valid medication action plan to the school; and
“A student may possess and self-administer medication at the school in which the student is currently enrolled, at school-sponsored activities, and while on school-sponsored transportation, to treat asthma, anaphylaxis, or other potentially life-threatening illness; provided, that:
“Sec. 3. Possession and self-administration of medication.
Section 3 of Law 17-52 added a section to read as follows:
For temporary (225 days) amendment of this section, see § 2(b) of School Sunscreen Safety Temporary Amendment Act of 2019 (D.C. Law 23-34, Dec. 24, 2019, 66 DCR 14300).